What can ATP content tell us about Barth syndrome muscle phenotypes? [PDF]
Brault JJ, Conway SJ.
europepmc +1 more source
Adaptive mechanisms in pancreatic islets counteract mitochondrial dysfunction in Barth syndrome. [PDF]
Carlein C +21 more
europepmc +1 more source
Tafazzin-deficient zebrafish display mitochondrial dysfunction, neutropenia, and metabolic defects without myopathy. [PDF]
Oyarbide U +10 more
europepmc +1 more source
Emerging roles of pyruvate dehydrogenase phosphatase 1: a key player in metabolic health. [PDF]
Kumar V, Greenberg ML.
europepmc +1 more source
Cranial, Renal, and Skeletal Anomalies in a Fetus With a Pathogenic Variant in the TAFAZZIN Gene. [PDF]
Muir CR, Gilmore KL, Singh S, Vora NL.
europepmc +1 more source
Contemporary insights into elamipretide's mitochondrial mechanism of action and therapeutic effects. [PDF]
Sabbah HN +8 more
europepmc +1 more source
Rescue of mitochondrial dysfunction through alteration of extracellular matrix composition in barth syndrome cardiac fibroblasts. [PDF]
PiƱeiro-Llanes J +8 more
europepmc +1 more source
ECG Findings Are Poor Predictors for Adverse Events and Cardiac Death in Barth Syndrome. [PDF]
Hutchinson A +3 more
europepmc +1 more source
State of the industry: integration of 3Rs principles and new approach methodologies in non-clinical product development through fit-for-purpose. [PDF]
Poppenborg SM, Webster DA, Carlsson B.
europepmc +1 more source
Mitochondrial cristae remodeling: Mechanisms, functions, and pathology. [PDF]
Yu J +7 more
europepmc +1 more source

